- €24.90m
- €74.27m
- €41.14m
- 35
- 56
- 12
- 23
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 19.5 | 38.8 | 15 | 12.9 | 41.1 |
Cost of Revenue | |||||
Gross Profit | 2.09 | 4.28 | 3.06 | 1.77 | 7.07 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18.2 | 34.6 | 13.1 | 12.6 | 35.1 |
Operating Profit | 1.3 | 4.22 | 1.88 | 0.235 | 6.02 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.02 | 3.96 | 1.69 | 1.34 | 3.47 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.33 | 3.85 | 1.73 | 1.33 | 3.47 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.956 | 2.59 | -0.022 | 1.4 | 1.17 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.956 | 2.59 | -0.022 | 1.4 | 1.17 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.333 | 0.61 | -0.006 | 0.358 | 0.049 |
Dividends per Share |